Hepatitis delta Advocacy Hub | UniteRare

At a Glance

Live from database

💊

Regulatory Watchboard

10 events

Apr 2026Phase III Clinical Trial of Hepalatide in Patients With Chronic Hepatitis D

Shanghai HEP Pharmaceutical Co., Ltd. — PHASE3

TrialNOT YET RECRUITING

Mar 2026A Phase III Study to Evaluate the Efficacy and Safety of Libevitug in Participants With Chronic HDV Infection (D-clear Study)

Huahui Health — PHASE3

TrialNOT YET RECRUITING

Feb 2026Phase 2b/3 Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide

Mirum Pharmaceuticals, Inc. — PHASE2, PHASE3

TrialRECRUITING

Feb 202610119473 -VIROMARKERS HDV Biomarkers Study

University of Rome Tor Vergata

TrialNOT YET RECRUITING

Feb 2026Oral-Periodontal Evaluation and Assessment of Oral Fluid Biomarkers in Patients With Hepatitis B+D

Research Center of Periodontal-Systemic Interactions

TrialRECRUITING

Feb 2026"Pregnancy and Viral Infections: Impact on Pregnant Women and Their Children. French Prospective Cohort"

ANRS, Emerging Infectious Diseases

TrialNOT YET RECRUITING

Jan 2026A Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-4)

Mirum Pharmaceuticals, Inc. — PHASE3

TrialRECRUITING

Oct 2025"Referral Attivo" Delta, Dallo Screening Alla Presa in Carico.

FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS

TrialRECRUITING

Sep 2025Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

TrialRECRUITING

Sep 2025Community Screening and Management of Hepatitis B, C and Delta in the Mongolian Population Living in France

Hospices Civils de Lyon — NA

TrialNOT YET RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

3 programs

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Patient Assistance Programs3

Ocuflox Ophthalmic Solution

Allergan, Inc.

OpenContact for details

HepaGam B

Cangene Corporation

OpenContact for details

Gamunex-C

Grifols Therapeutics, Inc.

OpenContact for details

View all support programs on disease page →

Approved Treatments

2 FDA-approved

Ocuflox Ophthalmic Solution

(Ofloxacin)Orphan drugstandard

Allergan, Inc.

Quinolone Antimicrobial [EPC]

FDA label ↗

HepaGam B

(hepatitis B immune globulin (human))Orphan drugstandard

Cangene Corporation

Human Immunoglobulin [EPC]

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

34 active trials

4Phase 3

4Phase 2

1N/A

22Unknown

2PHASE2, PHASE3

1PHASE1, PHASE2

34Total recruiting

Search clinical trials for Hepatitis delta →

Recent News & Research

No recent news articles indexed yet for Hepatitis delta.
Search PubMed for Hepatitis delta →

Browse all Hepatitis delta news →

Specialist Network

Top 6 by expertise

Fabien ZOULIM

Hôpital de la Croix-Rousse

Score 301 trial1 pub

Theo Heller, M.D.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

📍 Bethesda, Maryland

Score 118 trials

Pavel Bogomolov, PhD

Moscow Regional Research and Clinical Institute (MONIKI)

Score 112 trials

Oyunbileg Janchiv

National Cacer Center of Monglia

Score 81 trial

Jürgen Rockstroh, MD

University Hospital, Bonn

Score 61 trial

Young-Suk Lim, M.D., Ph.D.

Asan Medical Center

Score 62 trials

View all Hepatitis delta specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰